As a metabolomics services provider offering bespoke solutions for the discovery of dynamic biomarkers, Sapient leverages its high throughput, mass spectrometry-based metabolomics platform to probe deeper into the human metabolome at a rate is unmatched for discovery. Our untargeted methods outperform other metabolomics companies in both speed and scalability, enabling us to rapidly assay >15,000 metabolite and lipid biomarkers per sample, across thousands of samples, and identify those that associate with early disease, disease progression, and drug response.
By pairing nontargeted data generation with advanced metabolomics data analysis services, including statistical and pathway analysis, we help identify robust biomarkers to understand disease biology, enrich clinical trials, and align patients, disease, and precision therapies. How does it work?
Learn more about why Sapient is the choice partner for nontargeted metabolomics services, and how we can work together to advance your drug programs at any phase. Use the sidebar to download our fact sheet or request services directly.
"(Required)" indicates required fields
You can schedule a meeting to discuss details and turnaround time using the link below.